Meg R Gerstenblith

Summary

Affiliation: University Hospitals Case Medical Center
Country: USA

Publications

  1. ncbi Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study
    Meg R Gerstenblith
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA
    Int J Cancer 131:E149-55. 2012
  2. ncbi Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy
    Meg R Gerstenblith
    Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Am Acad Dermatol 66:312-6. 2012
  3. ncbi Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Dig Dis Sci 55:2735-43. 2010
  4. ncbi Hereditary genodermatoses with cancer predisposition
    Meg R Gerstenblith
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20892 7236, USA
    Hematol Oncol Clin North Am 24:885-906. 2010
  5. ncbi Ultraviolet radiation and melanoma
    Holly E Kanavy
    Department of Dermatology, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
    Semin Cutan Med Surg 30:222-8. 2011
  6. ncbi Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis
    Meg R Gerstenblith
    Genetic Epidemiology Branch Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Pigment Cell Melanoma Res 23:587-606. 2010

Detail Information

Publications6

  1. ncbi Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study
    Meg R Gerstenblith
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA
    Int J Cancer 131:E149-55. 2012
    ..Nevertheless, it may at least partly reflect residual UVR confounding. Further research with more detailed sun exposure data, including clothing patterns, would help clarify the relationship between BMI and BCC...
  2. ncbi Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy
    Meg R Gerstenblith
    Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Am Acad Dermatol 66:312-6. 2012
    ..Intravenous immunoglobulin (IVIG) is used to treat many inflammatory and autoimmune disorders and although generally well tolerated, cutaneous side effects occur...
  3. ncbi Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Dig Dis Sci 55:2735-43. 2010
    ....
  4. ncbi Hereditary genodermatoses with cancer predisposition
    Meg R Gerstenblith
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20892 7236, USA
    Hematol Oncol Clin North Am 24:885-906. 2010
    ..Early recognition and diagnosis allows for close follow-up and surveillance for associated malignancies...
  5. ncbi Ultraviolet radiation and melanoma
    Holly E Kanavy
    Department of Dermatology, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
    Semin Cutan Med Surg 30:222-8. 2011
    ....
  6. ncbi Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis
    Meg R Gerstenblith
    Genetic Epidemiology Branch Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
    Pigment Cell Melanoma Res 23:587-606. 2010
    ..As with any GWAS, the identified loci may not include the causal variants and may need confirmation by direct genome sequencing...